Kim Sablich
2018 - Myovant Sciences Ltd.
In 2018, Kim Sablich earned a total compensation of $2.4M as Chief Commercial Officer at Myovant Sciences Ltd..
Compensation breakdown
| Bonus | $105,000 |
|---|---|
| Non-Equity Incentive Plan | $47,000 |
| Option Awards | $1,474,406 |
| Salary | $133,333 |
| Stock Awards | $513,216 |
| Other | $87,958 |
| Total | $2,360,913 |
Sablich received $1.5M in option awards, accounting for 62% of the total pay in 2018.
Sablich also received $105K in bonus, $47K in non-equity incentive plan, $133.3K in salary, $513.2K in stock awards and $88K in other compensation.
Rankings
In 2018, Kim Sablich's compensation ranked 4,916th out of 14,244 executives tracked by ExecPay. In other words, Sablich earned more than 65.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,916 out of 14,244 | 66th |
Division Manufacturing | 1,845 out of 5,759 | 68th |
Major group Chemicals And Allied Products | 675 out of 2,122 | 68th |
Industry group Drugs | 565 out of 1,811 | 69th |
Industry Pharmaceutical Preparations | 434 out of 1,385 | 69th |
Source: SEC filing on July 25, 2019.
Sablich's colleagues
We found four more compensation records of executives who worked with Kim Sablich at Myovant Sciences Ltd. in 2018.